Literature DB >> 10677169

Molecular determinants of colon cancer metastasis.

C A Portera1, R S Berman, L M Ellis.   

Abstract

Colon cancer metastasis is a tightly regulated process that requires a cancer cell to express genes that allow progression through various distinct steps. Aberrations in gene expression by cancer cells leads to transformation, growth, angiogenesis, invasion, dissemination and survival in the circulation, attachment in the organ of metastasis, and again invasion, growth, and angiogenesis. In addition to the genotype/phenotype of the tumor cell, for a tumor cell to become a clinically relevant metastasis, it must be able to respond appropriately to the environment. This includes being able to utilize growth factors and blood vessels from the organ of metastasis for the benefit of the tumor mass. Understanding the molecular and biologic mechanisms of colon cancer metastasis will allow the development of rationale therapeutic strategies that are more likely to impact the natural history of this disease than current therapies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10677169     DOI: 10.1016/s0960-7404(99)00020-1

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  13 in total

1.  Port-site metastasis after minimally invasive cancer surgery.

Authors:  B Shpitz; E Klein
Journal:  Surg Endosc       Date:  2003-06-13       Impact factor: 4.584

2.  Role of beta-arrestin 1 in the metastatic progression of colorectal cancer.

Authors:  F Gregory Buchanan; D Lee Gorden; Pranathi Matta; Qiong Shi; Lynn M Matrisian; Raymond N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

3.  Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer.

Authors:  Akira Naruke; Mizutomo Azuma; Atsuko Takeuchi; Kenji Ishido; Chikatoshi Katada; Tohru Sasaki; Katsuhiko Higuchi; Satoshi Tanabe; Makoto Saegusa; Wasaburo Koizumi
Journal:  Gastric Cancer       Date:  2014-03-21       Impact factor: 7.370

4.  Assessment of differential gene expression patterns in human colon cancers.

Authors:  A Hernandez; F Smith; Q Wang; X Wang; B M Evers
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

5.  Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer.

Authors:  Hisashi Onodera; Akira Mori; Satoshi Nagayama; Akihisa Fujimoto; Tsuyoshi Tachibana; Yoshikuni Yonenaga; Tatsuaki Tsuruyama
Journal:  Int J Colorectal Dis       Date:  2005-04-22       Impact factor: 2.571

6.  Gene profiles between non-invasive and invasive colon cancer using laser microdissection and polypeptide analysis.

Authors:  Jin-Shui Zhu; Hua Guo; Ming-Quan Song; Guo-Qiang Chen; Qun Sun; Qiang Zhang
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

7.  Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma.

Authors:  Jing Wang; Ashwani Rajput; Julie L C Kan; Rebecca Rose; Xiao-Qiong Liu; Karen Kuropatwinski; Jennie Hauser; Alexander Beko; Ivan Dominquez; Elizabeth A Sharratt; Lisa Brattain; Charles Levea; Feng-Lei Sun; David M Keane; Neil W Gibson; Michael G Brattain
Journal:  J Biol Chem       Date:  2009-02-18       Impact factor: 5.157

8.  Rat colon carcinoma cells that survived systemic immune surveillance are less sensitive to NK-cell mediated apoptosis.

Authors:  Jurjen H L Velthuis; Miranda Stitzinger; Remco I J M Aalbers; Hans J G M de Bont; Gerard J Mulder; Peter J K Kuppen; J Fred Nagelkerke
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.

Authors:  Jaw-Yuan Wang; Jan-Sing Hsieh; Mei-Yin Chang; Tsung-Jen Huang; Fang-Ming Chen; Tian-Lu Cheng; Ketil Alexandersen; Yu-Sheng Huang; Wen-Shyong Tzou; Shiu-Ru Lin
Journal:  World J Surg       Date:  2004-06-08       Impact factor: 3.352

10.  Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.

Authors:  Bogdan Zalewski
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.